Jennifer Grossman, PhD
Sr. Scientist, Alliance Management
Dr. Grossman leads NCL's Alliance Management Division, which has established and managed productive collaborations within NCI, FDA, NIST and a network of over 150 drug development labs in industry and academia. Jennifer’s areas of expertise include nuclear magnetic resonance (NMR) of proteins and nanoparticles, and biophysical modeling of nanoparticle structures and interactions. She has experience in a variety of issues related to nanotech drug development and regulation and is a member of several working groups related to nano-bioinformatics, nanomedicine, and other nanotechnology issues. Prior to joining the NCL in 2006, Jennifer conducted research in Physical Chemistry at the University of Maryland, where she focused on modeling and measuring protein motion under the guidance of Dr. David Fushman, Professor of Biochemistry. She holds a Ph.D. in Physical Chemistry, an M.S. in Chemical Physics and a B.S. in Physics.